Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the Intracranial Paclitaxel Drug-eluting Balloon Catheters (SeQuent® Please CIS) in the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis and Restenosis After Interventional Therapy

NCT06047964 is registered in ClinicalTrials.gov with B. Braun Medical International Trading Company Ltd. as lead sponsor.

NCT NCT06047964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the Intracranial Paclitaxel Drug-eluting Balloon Catheters (SeQuent® Please CIS) in the Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis and Restenosis After Interventional Therapy
Lead sponsor
B. Braun Medical International Trading Company Ltd.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 23, 2023
Completion date
September 30, 2026
Enrollment
281 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial atherosclerotic stenosis, stroke